Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yoshimura

Showing results (251-260 of 362) with videos related to

Pageof 37
Sort By:
Surgery Today|January 1, 1995
Successful management of portal hypertension following artificial arterioportal shunting: report of a caseS Ko, Y Nakajima, H Kanehiro, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1997
Pheochromocytoma in a long-term hemodialysis patient, discovered as an adrenal incidentalomaS Asaka, Y Takayama, S Tagawa, et al.
Journal of Periodontal Research|July 2, 2013
Occlusal trauma accelerates attachment loss at the onset of experimental periodontitis in ratsS Nakatsu, Y Yoshinaga, A Kuramoto, et al.
Cancer Research|June 15, 1989
Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell lineM Kamiwatari, Y Nagata, H Kikuchi, et al.
International Journal of Immunogenetics|January 24, 2006
Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitusR Ni, K Ihara, K Miyako, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1990
[Studies on 5-FU concentration and thymidine phosphorylase activity in tissues of patients with colorectal cancer after SF-SP administration]K Yamada, S Hase, A Yoshimura, et al.
Oncogene|January 11, 2012
STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesisY Sekine, O Ikeda, A Mizushima, et al.
Kidney International|March 1, 1996
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized ratsV Kliem, R J Johnson, C E Alpers, et al.
Anticancer Research|November 1, 1995
Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancerA Gemma, S Kudoh, A Yoshimura, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 28, 1999
Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domainA Sasaki, H Yasukawa, A Suzuki, et al.
Pageof 37

Showing results (251-260 of 362) with videos related to

Sort By:
Pageof 37
Surgery Today|January 1, 1995
Successful management of portal hypertension following artificial arterioportal shunting: report of a caseS Ko, Y Nakajima, H Kanehiro, et al.
Internal Medicine (Tokyo, Japan)|June 1, 1997
Pheochromocytoma in a long-term hemodialysis patient, discovered as an adrenal incidentalomaS Asaka, Y Takayama, S Tagawa, et al.
Journal of Periodontal Research|July 2, 2013
Occlusal trauma accelerates attachment loss at the onset of experimental periodontitis in ratsS Nakatsu, Y Yoshinaga, A Kuramoto, et al.
Cancer Research|June 15, 1989
Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell lineM Kamiwatari, Y Nagata, H Kikuchi, et al.
International Journal of Immunogenetics|January 24, 2006
Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitusR Ni, K Ihara, K Miyako, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1990
[Studies on 5-FU concentration and thymidine phosphorylase activity in tissues of patients with colorectal cancer after SF-SP administration]K Yamada, S Hase, A Yoshimura, et al.
Oncogene|January 11, 2012
STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesisY Sekine, O Ikeda, A Mizushima, et al.
Kidney International|March 1, 1996
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized ratsV Kliem, R J Johnson, C E Alpers, et al.
Anticancer Research|November 1, 1995
Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancerA Gemma, S Kudoh, A Yoshimura, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 28, 1999
Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domainA Sasaki, H Yasukawa, A Suzuki, et al.
Pageof 37